Öz
Kaynakça
- 1. Goenka AH, Herts BR, Obuchowski NA, Primark AN, Dong F, Karim W, Baker ME. Effect of reduced radiation exposure and iterative reconstruction on detection of lowcontrast low-attenuation lesions in an anthropomorphic liver phantom: an 18-reader study. Radiology 2014; 1:154–1632. Erdi YE. Quantification of thyroid volume. Journal of Nuclear Medicine 1997; 6:1002.3.Hamilton D. Single Photon Planar Imaging. In. Hamilton D, David I (Eds). Single Photon Planar Imaging Diagnostic Nuclear Medicine A Physics Perspective. 1st Edition. Berlin: Springer, 2004; pp 115-136.4. Aliyev A, Metin H. Tiroit Kanserlerinde Tek Foton Emisyon Tomografisi/Bilgisayarlı Tomografi Görüntüleme. Nuclear Medicine Seminars / Nükleer Tıp Seminerleri 2016; pp 21-30.5. Rockoff SD, Goodenough DJ, McIntire KR. Theoretical limitations in the immunodiagnostic imaging of cancer with computed tomography and nuclear scanning. American Association for Cancer Research 1980; 8: 3054-3058.6. Bradwell AR, Fairweather DS, Dykes PW, Keeling A, Vaughan A, Taylor J. Limiting factors in the localization of tumors with radiolabeled antibodies, Immunology Today 1985; 5:163-170.7. Meikle SR, Dahlbom M. Positron emission tomography. In: Murray IPC., Ell PJ (Eds). Nuclear medicine in clinical diagnosis and treatment. New York: Churchill Livingston , 2006; pp 350-351.8. Maurer AH, Caroline DF, Jadali FJ, Manzone TA, Maier WP, Au FC, Schnall SF. Limitations of craniocaudal thallium-201 and technetium-99m-sestamibi mammoscintigraphy, Journal of Nuclear Medicine 1995; 9:1696-1700.9. Weber W, Bartenstein P, Gross MW, Kinzel GD, Daschner H, Feldmann HJ, Reidel G., Ziegler SI, Lumenta C, Molls M, Schwaiger M. Flourine-18-FDG PET and Iodine-123-IMT SPECT in the evaluation of brain tumors, Journal of Nuclear Medicine 1997; 5:802-808.10. Erdi AK, Erdi YE, Yorke ED, Wessels BW. Treatment planning for radioimmunotherapy, Physics in Medicine and Biology 1996; 10:2009-2026.11. Goodenough DJ, Atkins FB. Theoretical limitations of tumor imaging. In: Srivastava S(Eds). Radiolabeled monoclonal antibodies for imaging and therapy, New York: Plenum Publishing Corporation, 1998; pp 152-155.12. Jaszczak RJ, Coleman RE, Whitehead FR. Physical factors affecting quantitative measurements using camera-based single photon emission computed tomography, IEEE Nuclear and Plasma Sciences Society 1981; 1:69-80.13. Rose A. The visual process. In: Rose A(Eds).Vision: Human and Electronics. 1st ed. New York: Plenum Press, 1973; pp 1-27.14. Schneider DF, Ojomo KA, Chen H, Sippel RS. Remnant Uptake as a Postoperative Oncologic Quality Indicator. Thyroid 2013; 10:1269-1276. 15. Bugby SL, Lees JE, Ng AH, Alqahtani MS, Perkins AC. Investigation of an SFOV hybrid gamma camera for thyroid imaging. Physica Medica 2016; 1: 290–296.16. Hassan FU, Mohan FK. Clinical Utility of SPECT/CT Imaging Post-Radioiodine Therapy: Does It Enhance Patient Management in Thyroid Cancer?, European Thyroid Journal 2015; 4:239–245.17.https://www.healthcare.siemens.com.au/molecular-imaging/spect-and-spect-ct/symbia-t. Retrieved January 2, 2019. 18.http://santaxweb.dk/wp-content/uploads/2016/08/THB_1014_web.pdf. Retrieved January 2, 2019.
Ayrıntılar
Birincil Dil
Türkçe
Konular
Sağlık Kurumları Yönetimi
Bölüm
Araştırma Makalesi
Yazarlar
Yağmur Ulusoy
*
0000-0003-0013-4618
Türkiye
Mert Karagöz
Türkiye
Nami Yeyin
Türkiye
Mustafa Demir
Türkiye
Yayımlanma Tarihi
28 Mart 2019
Gönderilme Tarihi
21 Şubat 2019
Kabul Tarihi
26 Mart 2019
Yayımlandığı Sayı
Yıl 2019 Cilt: 41 Sayı: 1